ArticleMolecular cancer therapeutics2018

Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood Ependymoma.

Andrew M Donson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.